# Melanotan I (afamelanotide, Scenesse)

Source: https://aminodesk.com/library/melanotan-i
Publisher: Amino Desk
Updated: 2026-11-17
Clinical review: pending

Melanotan I is the research name for afamelanotide. The FDA approved it in 2019 as Scenesse, a small implant placed under the skin by a trained clinician, for adults with a rare inherited disorder that makes sunlight painful. It is not approved for tanning.

- **Legal lane:** FDA-approved for one rare condition, prescription only
- **Evidence grade:** A for its approved use
- **Form:** 16 mg dissolving implant inserted every 2 months
- **Brand:** Scenesse

## What it is

Afamelanotide is a synthetic copy of alpha-melanocyte-stimulating hormone, the signal that tells skin to make melanin. It is a different molecule from [Melanotan II](https://aminodesk.com/library/melanotan-ii), which acts on more receptors and also affects libido and appetite.

## What the evidence shows

The approval rested on three placebo-controlled trials in 244 adults with erythropoietic protoporphyria (EPP), a condition where light exposure causes severe pain. People with the implant could spend more time in direct sunlight without pain than people with a dummy implant.

No trial has tested afamelanotide for cosmetic tanning in people without EPP.

## Dosing on the label

One 16 mg implant is inserted under the skin above the hip bone every 2 months by a healthcare professional trained in the procedure. Patients are watched for 30 minutes afterward.

**No dose is established for injected Melanotan I.** The powder vials sold online are not the approved product. The implant releases the drug slowly over weeks; an injection of loose powder does not, and nobody has studied what it does.

## Side effects and warnings

- Implant-site reactions were the most common, followed by nausea, throat pain, cough, fatigue, dizziness and sleepiness.
- It darkens skin and existing moles. The label recommends a full-body skin check twice a year to monitor moles.

## Common questions

### Is Melanotan I approved for tanning?

No. As Scenesse, it is FDA-approved only for adults with erythropoietic protoporphyria, a rare disorder that makes sunlight painful.

### Is Melanotan I the same as Melanotan II?

No. They are different molecules. Melanotan II acts on more receptors and also affects libido and appetite.

### How is Scenesse given?

One 16 mg implant is inserted under the skin every 2 months by a trained healthcare professional. No dose is established for injected Melanotan I powder.

Added in the latest update. These answers summarize the sections above; sources are listed below.

## Sources

- [FDA label: Scenesse (afamelanotide) implant](https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210797s000lbl.pdf)
- [FDA Drug Trials Snapshot: Scenesse](https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-scenesse)

---
Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL.
